Back to Journals » Drug Design, Development and Therapy » Volume 10

miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism

Total article views   Abstract views HTML views PDF downloads Totals
5,459 Dovepress* 3,742 982+ 1,388 4,724
PubMed Central* 0 735 294 735
Totals 3,742 1,717 1,682 5,459
*Since 24 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar